Evidence map›Paper›PMID 25223481›Full record

ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2014

Reply to the letter to the editor 'The link between type 2 diabetes and pancreatic adenocarcinoma is yet to be established' by Rahman and Meeran.

C Bosetti, G M Petersen, D Li, C La Vecchia, Pancreatic Cancer Case-Control Consortium (PanC4)

Abstract readLetterComment
In one paragraph

Article in Annals of oncology : official journal of the European Society for Medical Oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

C BosettiDepartment of Epidemiology, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy;. Electronic address: cristina.bosetti@marionegri.it.
G M PetersenDepartment of Health Sciences Research, Medicine and Medical Genetics, Mayo Clinic, Rochester.
D LiDepartment of Gastrointestinal Medical Oncology, UT M.D. Anderson Cancer Center, University of Texas, Houston, USA.
C La VecchiaDepartments of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
Pancreatic Cancer Case-Control Consortium (PanC4)

Funding

Tissue CoreP50CA102701 · NCI · MAYO CLINIC ROCHESTER · PI PETERSEN, GLORIA M. · 2004 to 2018
$32.7M
NCI NIH HHS P50 CA102701
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes Mellitus, Type 2FemaleHumansHypoglycemic AgentsMalePancreatic NeoplasmsHypoglycemic Agents

Identifiers

PMID25223481
PMCPMC6122845

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.